Book Value per Share: Third Harmonic Bio Inc. (THRD)

Graphic logo of Third Harmonic Bio (THRD)

The development of immune drugs for allergies remains independent of economic cycles, as evidenced by the book value per share trend, where the current parameter equals 6.07. Third Harmonic Bio (THRD) attracts leading scientists through the uniqueness of its technologies. The primary growth driver will be the upcoming trial results for its urticaria inhibitor, while current R&D expenses are already priced in by investors.

Third Harmonic Bio Inc. (THRD): Share Book Value from 04/28/2023 to 08/16/2025

thirdharmonicbio.com - analytical breakdowns and key metrics (THRD)

- price and consensus price forecast:
Price Chart Third Harmonic Bio, Inc|THRD - Fair Value Consensus
- market capitalization data:
Market Capitalization Third Harmonic Bio, Inc.|THRD - Business Value
- book capitalization data:
Net Assets per Single Share Third Harmonic Bio|THRD - Net Asset Value|Market Capitalization to Book Value Ratio thirdharmonicbio.com|THRD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Third Harmonic Bio|THRD - Long-Term Debt to Capital|Short-Term Debt to Equity Third Harmonic Bio, Inc.|THRD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Third Harmonic Bio, Inc.
Fundamental company valuation:Third Harmonic Bio, Inc - THRD
Manufactured products of Third Harmonic Bio, Inc.

The book value per share, equal to 6.07, determines the equity portion per security, measuring the actual value of net assets minus all liabilities. By analyzing the book value per share chart, an investor can assess the financial stability of Third Harmonic Bio (THRD) amid a lack of profitability and risks associated with dependence on a single immunology drug.

Competitors of Third Harmonic Bio (THRD)

Net Assets per Single Share Argenx (ARGX)|BNTX - Accounting Value of a Share|Book Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Accounting Value per Share Astria Pharma ATXS|ENGN - Book Price of a Share|Book Value per Share RAPT Therapeutics, Inc. RAPT|Aerovate Therapeutics (JBIO) - Accounting Value of a Share|ACRS: Book Value per Share|Net Assets per Share KYTX|Tiziana Life Sciences PLC (TLSA) - Net Assets per Single Share|Accounting Value of a Share Cabaletta Bio Inc (CABA)|VTYX - Book Value per Share|THTX - Equity per Share|Accounting Value per Share Avalo Therapeutics (AVTX)|ELDN - Accounting Value of a Share|Book Value per Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|ZURA (Zura Bio Limited) - Book Value per Share|Book Value per Share ATYR|Adagene (ADAG) - Net Assets per Single Share|Accounting Value of a Share IMA (ikenaoncology.com)|Shattuck Labs - Net Assets per Single Share|Equillium Inc - Accounting Value per Share|CNTB (Connect Pharma) - Net Assets per Single Share|IMUX: Net Asset Value per Share|Net Assets per Single Share atarabio.com|InflaRx (IFRX) - Equity per Share|XFOR: Book Value per Share|Net Assets per Share Adicet|Book Value per Share CELU (Celularity Inc.)|Accounting Value per Share inmunebio.com INMB|Accounting Value per Share Barinthus Biotherapeutics plc|Accounting Value of a Share Kezar Life Sciences Inc. KZR|SABS - Book Value per Share|AKTX - Net Assets per Single Share|enlivex.com - Book Value per Share|QTTB (Q32 Bio) - Net Assets per Share|Net Assets per Single Share GOVX (GeoVax)|Net Asset Value per Share Edesa Biotech Inc (EDSA)|Accounting Value per Share iBio Corp|Book Price of a Share carismatx.com (CARM)|Book Value per Share XTL Biopharmaceuticals|Bolt Biotherapeutics Inc. - Accounting Value of a Share|Net Assets per Single Share HCW Biologics Inc (HCWB)|APVO - Accounting Value of a Share|Book Value per Share AIM ImmunoTech|ADTX (Aditxt, Inc.) - Equity per Share|Net Assets per Single Share GRI Bio, Inc. GRI|Share Book Value xortx.com|Vyome Holdings (HIND) - Book Value per Share|Accounting Value of a Share Revelation Biosciences Inc (REVB)|Book Value per Share INDP (Indaptus)|BiondVax Pharmaceuticals - Book Value per Share|Net Assets per Single Share CalciMedica Corp (CALI)|AFMD: Accounting Value of a Share|ALLK (allakos.com) - Net Assets per Single Share|HOOKIPA Pharma (HOOK) - Accounting Value per Share|IGMS (IGM Biosciences Inc.) - Book Value per Share|Book Value per Share iTeos Pharma (ITOS)|Ocean Biomedical, Inc. (OCEA) - Accounting Value per Share|Accounting Value of a Share tcbiopharm.com (TCBP)